Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional, Cross-sectional Study to Describe NOACs Management ss in Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.

NCT03285373 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03285373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03285373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional, Cross-sectional Study to Describe NOACs Management ss in Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
November 29, 2017
Completion date
January 31, 2019
Enrollment
1,008 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation